The Effects of Raspberry Leaf Tea on Blood Glucose Control
Launched by UNIVERSITY OF READING · Apr 24, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how raspberry leaf tea might affect blood sugar levels after eating sugary foods. Researchers want to find out if the natural compounds in raspberry leaves can help lower the rise in blood sugar and insulin that happens after consuming sucrose, a type of sugar. The study will involve 20 healthy adults aged 18 to 65 who do not smoke, have no serious medical conditions, and are not taking certain medications or supplements that could affect their blood sugar levels.
Participants in this study will attend four visits over several months. After fasting overnight, they will drink a sugary solution mixed with either raspberry leaf tea or a control drink. Blood samples will be taken at different times to measure their blood sugar and insulin levels. To participate, individuals need to have normal blood sugar levels and meet other specific health criteria, such as not being pregnant or using herbal medicines in the past three months. This study is a great opportunity for eligible individuals to contribute to research that could help understand natural ways to manage blood sugar.
Gender
ALL
Eligibility criteria
- The volunteer inclusion criteria are:
- • Fasting blood glucose in the range \< 5.5 mmol/l (at day 0)
- • A signed consent forms.
- • Age 18-65 years
- • Body mass index ≤ 34.9 kg/m2
- • Non-smoking
- • No pregnancy/lactation
- • No use of herbal medicines for at least the previous three months
- • Not on a weight loss program six months before screening
- • Not involved in clinical trial six months before screening
- • Not had severe cardiac, hepatic, or renal function impairment
- The volunteer exclusion criteria are:
- • Smoking
- • Pregnancy/lactation
- • Use of herbal medicines for at least the previous three months
- • Involved in a weight loss program six months before screening.
- • Involved in clinical trial six months before the screening.
- • Had severe cardiac, hepatic, or renal function impairment.
- • Sufferers of chronic illnesses
- • Individuals with food allergies
- • People with prediabetes or diabetes
- • People with coeliac disease
About University Of Reading
The University of Reading is a prestigious research institution in the United Kingdom, renowned for its commitment to advancing knowledge across various disciplines, including health sciences. As a clinical trial sponsor, the university leverages its cutting-edge research facilities and interdisciplinary expertise to conduct innovative studies aimed at improving healthcare outcomes. With a strong emphasis on ethical research practices and collaboration with industry partners, the University of Reading strives to contribute valuable insights to the field of medicine, fostering the development of new treatments and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reading, Berkshire, United Kingdom
Patients applied
Trial Officials
Jeremy Spencer, PhD
Principal Investigator
University of Reading
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported